Louisiana State Employees Retirement System Lowers stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : Louisiana State Employees Retirement System reduced its stake in Johnson & Johnson by 4.75% during the most recent quarter end. The investment management company now holds a total of 184,600 shares of Johnson & Johnson which is valued at $20,689,968 after selling 9,200 shares in Johnson & Johnson , the firm said in a disclosure report filed with the SEC on Apr 25, 2016.Johnson & Johnson makes up approximately 1.07% of Louisiana State Employees Retirement System’s portfolio.

Johnson & Johnson opened for trading at $112.22 and hit $112.7897 on the upside on Monday, eventually ending the session at $112.75, with a gain of 0.60% or 0.67 points. The heightened volatility saw the trading volume jump to 51,78,847 shares. Company has a market cap of $311,118 M.

Other Hedge Funds, Including , Wilbanks Smith Thomas Asset Management reduced its stake in JNJ by selling 368 shares or 0.58% in the most recent quarter. The Hedge Fund company now holds 62,963 shares of JNJ which is valued at $7,056,893. Johnson & Johnson makes up approx 0.84% of Wilbanks Smith Thomas Asset Management’s portfolio.Trillium Asset Management reduced its stake in JNJ by selling 870 shares or 0.91% in the most recent quarter. The Hedge Fund company now holds 94,436 shares of JNJ which is valued at $10,701,488. Johnson & Johnson makes up approx 0.69% of Trillium Asset Management’s portfolio.Centurylink Investment Management Co boosted its stake in JNJ in the latest quarter, The investment management firm added 726 additional shares and now holds a total of 42,314 shares of Johnson & Johnson which is valued at $4,795,022. Johnson & Johnson makes up approx 1.71% of Centurylink Investment Management Co’s portfolio.Crossvault Capital Management boosted its stake in JNJ in the latest quarter, The investment management firm added 150 additional shares and now holds a total of 40,278 shares of Johnson & Johnson which is valued at $4,564,303. Johnson & Johnson makes up approx 3.32% of Crossvault Capital Management’s portfolio.Wunderlich Securities boosted its stake in JNJ in the latest quarter, The investment management firm added 185 additional shares and now holds a total of 4,083 shares of Johnson & Johnson which is valued at $449,865. Johnson & Johnson makes up approx 0.67% of Wunderlich Securities’s portfolio.

On the company’s financial health, Johnson & Johnson reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.65. The company had revenue of $17482.00 million for the quarter, compared to analysts expectations of $17491.02 million. The company’s revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.

Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by RBC Capital Mkts on Apr 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 125 from a previous price target of $122 .Company shares were Reiterated by Piper Jaffray on Apr 20, 2016 to “Neutral”, Firm has raised the Price Target to $ 106 from a previous price target of $105 .Company shares were Reiterated by RBC Capital Mkts on Apr 15, 2016 to “Outperform”, Firm has raised the Price Target to $ 122 from a previous price target of $114 .

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Leave a Reply

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.